The pharmacological agents for managing IBD (both UC and CD) include glucocorticoids, immunomodulators [42], and anti-TNF-α biological agents [43,44], as well as inhibitors of molecular pathways [45]. This evidence concerns the gene TNF and inflammatory bowel disease.